The sensitivity of ORTHO(TM) HCV 3.0 ELISA Test System (ELISA 3) for t
he detection of anti-HCV was compared with the second-generation ELISA
, ORTHO HCV 2.0 ELISA Test System (ELISA 2). ELISA 3 differs from ELIS
A 2 in that it incorporates the HCV recombinant antigen NS5, in additi
on to recombinant antigens derived from the NS3, NS4 and core regions
of the HCV genome. Specimens tested consisted of serial bleeds obtaine
d from 21 individuals undergoing seroconversion following acquisition
of post-transfusion HCV infection. ELISA 3 demonstrated significantly
greater sensitivity than ELISA 2, detecting seroconversion earlier in
24% (5/21) of cases. Although one of these cases appeared to represent
early seroconversion to NS5, most of the improved sensitivity of ELIS
A 3 appeared to derive from increased detectability of anti-c33c.